Welcome to our dedicated page for Zomedica news (Ticker: ZOM), a resource for investors and traders seeking the latest updates and insights on Zomedica stock.
Zomedica Corp (NYSE American: ZOM) delivers innovative veterinary health solutions through advanced diagnostics and therapeutic technologies for companion animals and equines. This dedicated news hub provides investors and veterinary professionals with timely updates on corporate developments directly impacting animal healthcare innovation.
Access official press releases covering product launches, financial results, and strategic partnerships that shape Zomedica's position in veterinary medicine. Our curated collection ensures transparent access to regulatory filings, technology advancements, and market expansion initiatives without promotional bias.
Key updates on Zomedica's diagnostic platforms including TRUFORMA® assays, therapeutic device innovations, and clinical validation studies. Monitor operational milestones affecting veterinary practice efficiencies and animal health outcomes through verified corporate communications.
Bookmark this page for streamlined access to Zomedica's latest developments. Combine regular visits with professional financial advice when making investment or practice management decisions related to veterinary healthcare technologies.
Zomedica Corp. (NYSE American: ZOM), a veterinary health company, announced that CEO Larry Heaton will provide a strategic update at the H.C. Wainwright Global Investment Conference on May 2, 2023, at 2:30 PM ET. This presentation will be available via webcast and can be accessed on Zomedica's website after the event.
Zomedica specializes in point-of-care diagnostics and therapeutic products for companion animals, such as dogs and cats. Their mission focuses on enhancing productivity and revenue for veterinarians while improving animal care. For more information about their products, visit www.zomedica.com.
Zomedica Corp. (NYSE American:ZOM) is set to be featured on The RedChip Money Report airing on Bloomberg TV on April 1, 2023, at 7 p.m. ET. This interview aims to provide insights into Zomedica's operations in the veterinary health sector, focusing on products for clinical veterinarians and enhancing animal care. The show, with an estimated reach of 73 million homes in the U.S., is part of RedChip Companies' effort to highlight microcap and small-cap stocks.
For complete access to the interview, visit here.
FAQ
What is the current stock price of Zomedica (ZOM)?
What is the market cap of Zomedica (ZOM)?
